154479 Prevalence and correlates of methamphetamine/amphetamine use among young adult injection drug users (IDUs) in five U.S. cities

Monday, November 5, 2007: 5:12 PM

Danielle C. Ompad, PhD , Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY
Mary H. Latka, PhD , Center for Urban Epidemiological Studies, New York Academy of Medicine, New York, NY
Steffanie A. Strathdee, PhD , Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
David W. Purcell, JD, PhD , Prevention Research Branch, Centers for Disease Control and Prevention, Atlanta, GA
Susan L. Bailey , Division of Epidemiology and Biostatistics, University of Illinois at Chicago, School of Public Health, Chicago, IL
Sharon M. Hudson, PhD , Health Research Association, Los Angeles, CA
Hanne Thiede, DVM, MPH , HIV/AIDS Epidemiology Program, Public Health- Seattle and King County, Seattle, WA
Vijay Nandi, MPH , Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY
Richard S. Garfein, PhD, MPH , Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA
Background: A growing body of literature suggests an expansion of methamphetamine/amphetamine (M/A) markets in many U.S. cities and an association between M/A use increased HIV infection risk.

Methods: In a cross-sectional study, we assessed correlates of recent (last three month) M/A use, irrespective of administration route, among 3243 15-30 year-old IDUs in cities with low (Baltimore, Chicago, New York) and high (Los Angeles, Seattle) prevalence of M/A use. Low and high prevalence cities were analyzed separately.

Results: Overall, the sample was predominantly male (69.3%), White non-Hispanic (64.0%), and heterosexual (72.6%). Prevalence of recent M/A use was 17.4% and 75.8% in low and high prevalence cities, respectively. In multivariate logistic regression analysis, models from both low and high prevalence cities revealed that when compared to non-M/A users, recent M/A users were less likely to be Black non-Hispanic and more likely to be homeless and have recently used cocaine, inhalants, or PCP. In low prevalence cities, compared with non-M/A users, recent M/A users were also less likely to be Hispanic and more likely to be heterosexual women and women-who-have-sex-with-women (WSW) (reference: heterosexual men), use crack and club drugs, and report five or more recent injection partners. In high prevalence cities, recent M/A users were also more likely to be MSM and share injection paraphernalia (e.g., cookers, cottons, water).

Conclusions: These findings highlight the importance of considering the local context of M/A use as well as emerging subpopulations (i.e., WSW and heterosexual women) of users when designing methamphetamine education, prevention, and treatment programs.

Learning Objectives:
1. Identify correlates of methampetamine/amphetamine use in five US urban areas. 2. Describe differences in methamphetamine/amphetamine use by city, race/ethnicity and sexual behavior. 3. Recognize methampetamine/amphetamine subgroups most in need of intervention.

Keywords: Substance Abuse Assessment, Injection Drug Users

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.